I am currently CSO of Carbon Biosciences, a venture-backed biotech company advancing novel non-AAV gene therapy vectors. Before joining Carbon in January 2023, I spent 9 years at Dicerna Pharmaceuticals, now a wholly owned subsidiary of Novo Nordisk, most recently as SVP Discovery Research. At Dicerna, I was fortunate to have led the effort to advance a new platform technology for delivery of genetic medicines, leading to multiple clinical programs and corporate partnerships. The first 17 years of my career were spent at Merck and Co, Inc. in drug discovery and early development, with a focus on both small molecules and oligonucleotide therapeutics. I am passionate about building research organizations, mentoring early-career scientists, advancing new pharmaceutical modalities, performing pioneering research in targeted delivery, and leading programs to impact underserved patient populations. I am a native of the Philadelphia area, and it’s great to be participating in this conference!
